When acute ischemic strokes (AIS) associates with coronavirus the outcome has being described as the most severe experience, a patient suffer from.
In a new research published yesterday in Stroke, a journal of the American Stroke Association, a division of the American Heart Association. It was pointed out that the experience leads to worse functional outcomes and are associated with higher mortality rates.
When AIS patients with COVID-19 were compared to non-COVID-19 patients, the following was discovered: 1
- COVID-19 patients had more severe strokes (median NIHSS score of 10 vs. 6, respectively);
- COVID-19 patients had higher risk for severe disability following stroke (median mRS score 4 vs. 2, respectively); and
- COVID-19 patients were more likely to die of AIS.
“The increased stroke severity at admission in COVID-19-associated stroke patients compared to the non-COVID-19 cohort may explain the worse outcomes. The broad, multi-system complications of COVID-19, including acute respiratory distress syndrome, cardiac arrhythmias, acute cardiac injury, shock, pulmonary embolism, cytokine release syndrome and secondary infection, probably contribute further to the worse outcomes including higher mortality in these patients. … The association highlights the urgent need for studies aiming to uncover the underlying mechanisms and is relevant for prehospital stroke awareness and in-hospital acute stroke pathways during the current and future pandemics.”